Veracyte Announces Positive Coverage Policy for the Afirma® Gene Expression Classifier from Health Care Service Corporation (HCSC) |
December 15, 2015 | December 2015 Bond Updates |
SOUTH SAN FRANCISCO, Calif., Dec. 14, 2015 /PRNewswire/ -- Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that Health Care Service Corporation (HCSC), an independent licensee of the Blue Cross and Blue Shield... |
View more at: http://www.prnewswire.com/news-releases/veracyte-announces-positive-coverage-policy-for-the-afirma-gene-expression-classifier-from-health-care-service-corporation-hcsc-300192526.html |
Related News |
|